Introduction
============

The feasibility of target detection in colorectal cancer (CRC) has been previously demonstrated in mice ^\[[@b1]-[@b4]\]^. Nevertheless, the question to be addressed is what the best candidate molecule/cell is to target. Cancer is proposed to be the disease of the stem cell as the stem cells are the only long-lived cells in a rapidly proliferating tissue such as the intestinal tract; the quality which makes them good candidates for accumulation of successive mutations required for the tumour evolution. In fact, stem cells are suggested to be responsible for tumour initiation, maintenance, and recurrence ^\[[@b5]\]^. Intestinal stem cells (ISCs) are believed to reside in the crypts of Lieberkühn; which are invaginations of the epithelial layer into the stroma. The stem cells are responsible for the physiologic rapid cellular turnover of the intestinal epithelium and its regeneration after injury. Murine experiments have clearly shown that tumourigenic hits can only result in an intestinal tumour if they happen in the stem cell compartment and not the transient-amplifying region ^\[[@b6]\]^. *Adenomatous polyposis coli* (APC) gene mutations that result in β-catenin activation, is the primary event in adenoma formation. It was observed that APC-driven adenoma originates either from a single or multiple APC-mutated Lgr5^+^ ISCs in mice ^\[[@b7]\]^. In addition, constitutive activation of Wnt pathway was found to increase the number of stem cells and consequent transformation of them ^\[[@b8]\]^. Recent evidence suggests differentiated intestinal epithelium can also be dedifferentiated and acquire stemness features upon constitutive Wnt pathway activation in chronic inflammatory milieu; which is capable of initiating the tumourigenesis process ^\[[@b9]\]^.

Bjerknes suggests that the mutant colon stem cells expand faster than normal counterparts. This does not however, imply a higher rate of cell cycle in the mutant stem cell. It might be that more dormant stem cells return to the active cycling state compared to normal ^\[[@b10]\]^. The first cellular alteration in familial adenomatous polyposis has been identified to be the 'proliferative shift' *i.e.* the upward migration of proliferative cells in an otherwise histologically normal mucosa. Boman *et al.* have employed computer simulation approach to understand the mechanism linking the existing *APC* mutation to cellular alterations in the crypt. It was noted that only an increase in the number of stem cells would consistently result in the upward shift of DNA synthesis. Moreover, 50% increase in the initial number of stem cells was sufficient to induce the phenomenon ^\[[@b11]\]^. In human gut, murine ISC marker Lgr5 expression was found to be limited to the base of the crypt in normal mucosa, but increased and shifted upward in adenoma and CRC ^\[[@b12]-[@b14]\]^. In adenoma, Lgr5^+^ cells were observed at an increased number compared to normal crypts and were not located at the base of the crypt. Instead they were most frequently seen at the luminal surface ^\[[@b14]\]^. The number of Lgr5^+^ cells increases in parallel with adenoma-carcinoma progression and generally they migrate upward towards the luminal surface ^\[[@b15]\]^. Overall, the evidence indicates expansion and upward shift of the Lgr5^+^ cell population in the course of CRC tumourigenesis.

Targeted intravital imaging of gastric, mammary, and glioblastoma cancer stem cells and normal stem cells in the hair follicle has been performed in mice ^\[[@b16]-[@b19]\]^. Recently, Ritsma *et al.* have developed an abdominal imaging window (AIW) which could be surgically implanted in mice and be maintained in place for up to a month. Lgr5^+^ ISCs were successfully imaged in a single crypt over a few days through AIW ^\[[@b20]\]^. Lgr5^+^ ISCs were also imaged by two-photon microscope in Lgr5-eGFP^+^ mice both *in vivo* and *ex vivo. In vivo* imaging was conducted following exteriorising a small intestinal loop on a glass slide. Lgr5^+^ ISCs were readily visualized at the depth of 70 μm in the small intestine and 217 μm in the colon ^\[[@b21]\]^.

Under normal circumstances only a limited number of ISCs exist at the base of the crypt. Increased number of ISCs and migration above the base of the crypt is an indication of stem cell expansion; which is speculated to be an early event in intestinal tumourigenesis. Therefore, targeted *in vivo* detection of ISCs and reconstruction of their position in relation to the base of the crypt could potentially be a powerful option for an integrative approach to CRC screening. To that end, a model is conceivable where a hypothetical line delineates the base of the crypt. Abnormal signal would then be defined as signal intensity more than the calculated average intensity *i.e.* hyperplasia of the stem cell and/or signal above the hypothetical boundary of the base of the crypt *i.e.* upward migration of the stem cell ([Figure1](#fig1){ref-type="fig"}).

![*Schematic presentation of stem cell in the colon crypts. Under normal state, a limited number of stem cells exist at the base of the crypt. When stem cell compartment is expanded, the number of stem cells is increased and they migrate upward along the axis of the crypt. s, number of stem cells in normal condition; n, number of stem cells; L, length of the crypt; Lb, length of the base of the crypt; Ls, localization of the stem cell* ](jsrm-09-038-g006){#fig1}

Intravital ISC imaging faces major conceptual as well as technological challenges. The categorical identity of ISCs is still controversial. It is suggested that two functionally distinct groups of stem cells exist in the murine small intestine ^\[[@b22]\]^; the relevance of which to intestinal tumourigenesis is unknown. Moreover, ISCs are as yet not categorically identified and characterised in human. It is possible that ISCs have intercryptal and intracryptal heterogeneity; the relevance of which to intestinal tumourigenesis and the level of complexity imposed on intravital imaging are unknown.

Assuming that ISCs are known, they should be selectively labelled prior to the imaging. The nature and composition of the contrast agent need to be carefully decided to achieve high level of selective contrast as well as minimum toxicity and immunogenicity. In addition, the administration route of the contrast agent *i.e.* topical *vs.* intravenous needs to be decided. The choice of the imaging modality is of paramount importance. A high-resolution imaging technique with high penetration depth and sufficiently large field of view should be employed. It is best if it could be designed as an adjunct to the regular colonoscope as it should be able to scan the entire area of the colon mucosa. Image output should be readily understandable by the attending clinician. A scoring system should be designed to quantify and classify the result in order to integrate it within a multimodality screening strategy. However, in order to clinically apply this hypothesis, it is imperative to answer the following questions. Firstly, it should be determined whether stem cell compartment expansion happens in early CRC lesions in human. Secondly, the predictive value of the phenomenon needs to be calculated through longitudinal large scale investigation of colon samples. Long term follow-up is required to relate stem cell compartment expansion with the outcome as defined as developing CRC. Thirdly, in order to get an estimate for the false positive rate, it should be ascertained whether stem cell compartment is altered in conditions other than CRC. Finally, the likelihood of developing a stem cell compartment expansion event into CRC should be measured.
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